Asia Pacific Brain Aneurysm Treatment Market Growth Drivers and Forecast by 2027

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027

Asia Pacific Brain Aneurysm Treatment Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Type (Surgery and Medication), Condition (Unruptured Aneurysm and Ruptured Aneurysm), End User (Hospitals and Clinics)

Report Date : Jun 2020
Report Code : TIPRE00011576

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 114

Page Updated: Jun 2020

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The Asia Pacificbrain aneurysm treatment market is expected to reach US$1,737.32millionby 2027from US$ 576.71millionin 2019. The market is estimated to grow at a CAGR of 14.9%from 2020 to 2027.

The growth of the market is attributed torise in research activities, increasing prevalence of brain aneurysm, and growingnumber of product launches. However, the high cost of procedureshinders the growth of the market in Asia Pacific.

The Asia Pacific brain aneurysm treatment market is expected to witness significant growth during the forecast period due to growingprevalence of associated risk factors such as hypertension and brain strokes. Also, players in the regional market might find growth opportunities with the rising number of market approvalsfor their products.For instance, in December 2019, Kaneka Corporation launched a new coil for embolization of brain aneurysm. The product is expected to offer more treatment options in geriatric population and patients with high blood pressure and other chronic conditions.

China is among the major countries in the brain aneurysm treatment market in this region. The growth of China brain aneurysm treatment market is prominently attributed to a rising prevalence of stroke and increasing research and development programs to innovate new treatment alternatives. As per the study published in the National Center for Biotechnology Information, the prevalence of unruptured intracranial aneurysm (UIA) is as high as 7% among 35–75-year-old individuals in China.

Additionally, rapid technological innovations and collaborations are boosting the brain aneurysm treatment market growth in the country. For instance, in 2019, LPIXEL Inc., a prominent leader in image analysis and processing, received an approval for EIRL aneurysm fromPharmaceuticals and Medical Devices Agency (PMDA) in Japan. The product is a deep learning-powered software thatcanbe used in identifying suspected aneurysms from brain MRI.

Asia Pacific Brain Aneurysm Treatment Market Revenue and Forecast to 2027 (US$ Million)

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Asia PacificBrain Aneurysm Treatment Market Segmentation

By Type

Surgery
Medication

By Condition

Unruptured Aneurysm
Ruptured Aneurysm

By End User

Hospitals
Clinics

By Country

China
Japan
India
South Korea
Australia
Rest of Asia Pacific

Company Profiles

Stryker Corporation
MicroPort Scientific Corporation
Terumo Corporation
KANEKA CORPORATION
Mizuho Medical Co,Ltd.

Asia Pacific Brain Aneurysm Treatment Report Scope

Report Attribute	Details
Market size in 2019	US$ 576.71 Million
Market Size by 2027	US$ 1,737.32 Million
Global CAGR (2020 - 2027)	14.9%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Type Surgery and Medication By Condition Unruptured Aneurysm and Ruptured Aneurysm By End User Hospitals and Clinics
Regions and Countries Covered	Asia-Pacific China India Japan Australia Rest of Asia-Pacific
Market leaders and key company profiles	Stryker Corporation MicroPort Scientific Corporation Terumo Corporation KANEKA CORPORATION Mizuho Medical Co,Ltd.

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Asia Pacific Brain Aneurysm Treatment Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy